BRCA2 controls DNA:RNA hybrid level at DSBs by mediating RNase H2 recruitment. by D'Alessandro, Giuseppina et al.
ARTICLE
BRCA2 controls DNA:RNA hybrid level at DSBs by
mediating RNase H2 recruitment
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DNA double-strand breaks (DSBs) are toxic DNA lesions, which, if not properly repaired, may
lead to genomic instability, cell death and senescence. Damage-induced long non-coding
RNAs (dilncRNAs) are transcribed from broken DNA ends and contribute to DNA damage
response (DDR) signaling. Here we show that dilncRNAs play a role in DSB repair by
homologous recombination (HR) by contributing to the recruitment of the HR proteins
BRCA1, BRCA2, and RAD51, without affecting DNA-end resection. In S/G2-phase cells,
dilncRNAs pair to the resected DNA ends and form DNA:RNA hybrids, which are recognized
by BRCA1. We also show that BRCA2 directly interacts with RNase H2, mediates its locali-
zation to DSBs in the S/G2 cell-cycle phase, and controls DNA:RNA hybrid levels at DSBs.
These results demonstrate that regulated DNA:RNA hybrid levels at DSBs contribute to HR-
mediated repair.
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DNA double-strand breaks (DSBs) are some of the mosttoxic DNA lesions, since their inaccurate repair mayresult in mutations that contribute to cancer onset and
progression, and to the development of neurological and immu-
nological disorders1. The formation of DSBs activates a cellular
response known as the DNA damage response (DDR), which
senses the lesion, signals its presence, and coordinates its
repair2,3. Following detection of DSB or resected DNA ends by
the MRE11-RAD50-NBS1 (MRN) complex or the single-strand
DNA binding protein replication protein A (RPA), respectively,
apical kinases, such as ataxia-telangiectasia mutated (ATM) and
ATM- and Rad3-related (ATR), are activated and phosphorylate
numerous targets, including the histone variant H2AX (named
γH2AX). The spreading of γH2AX along the chromosome favors
the recruitment of additional DDR proteins, including p53-
binding protein (53BP1) and breast cancer 1 (BRCA1), which
accumulate in cytologically detectable DDR foci4. In mammalian
cells, DSBs are mainly repaired by ligation of the broken DNA
ends in a process known as nonhomologous end-joining
(NHEJ)5. However, during the S/G2 cell-cycle phase, DSBs
undergo resection, which directs repair toward homology-based
mechanisms6. DNA-end resection is a process initiated by the
coordinated action of the MRE11 nuclease within the MRN
complex, together with C-terminal binding protein interacting
protein (CtIP), and continued by the nucleases including exo-
nuclease 1 (EXO1) or DNA27. Resected DNA ends are coated by
RPA, which contributes to DDR signaling and undergoes a DNA
damage-dependent hyperphosphorylation8. When com-
plementary sequences are exposed upon resection of both the
DSB ends, RAD52 mediates their annealing via a process called
single-strand annealing (SSA) resulting in the loss of genetic
information6. Alternatively, a homologous sequence located on
the sister chromatid or on the homologous chromosome can be
used as a template for repair in a process known as homologous
recombination (HR)9. The invasion of the homologous sequence
is mediated by the recombinase RAD51, whose loading on the
ssDNA ends is promoted by breast cancer 2 (BRCA2), which
binds BRCA1 through the partner and localizer of BRCA2
(PALB2)10,11. BRCA1, together with its constitutive heterodimer
BARD1, is a multifaceted protein with several roles in DDR
signaling and repair12. BRCA1 and BRCA2 genes are the most
frequently mutated genes in breast and ovarian cancers13 and
recently developed drugs, such as poly(ADP-ribose) polymerases
(PARP) inhibitors, selectively target cancer cells harboring
mutations in these genes14. Among its several functions, BRCA1
promotes DNA-end resection, mainly by counteracting the
inhibitory effect of 53BP115. Indeed, the HR defect in BRCA1-
deﬁcient cells is rescued by the depletion of 53BP116.
Recently, a novel role for RNA in the DNA damage signaling and
repair has emerged17–25. In particular, we have reported that RNA
polymerase II (RNA pol II) is recruited to DSBs, where it synthe-
sizes damage-induced long noncoding RNAs (dilncRNAs)17,18.
DilncRNAs are processed to generate DNA damage response RNAs
(DDRNAs), which promote DDR signaling17,18,21,25,26. Similar
RNA molecules, named diRNAs, contribute to DSB repair by
HR22–24.
It has recently been demonstrated that DNA:RNA hybrids
form at DSBs in a tightly regulated fashion in Schizosacchar-
omyces pombe27 and in mammalian cells28–31. However, DNA:
RNA hybrid formation at DSBs in mammalian cells has not been
investigated in depth yet, nor has any characterization of the
molecular mechanisms leading to their formation or metabolism
at DSBs been reported. Control of DNA:RNA hybrid levels can be
achieved either by avoiding their formation during transcription,
or by unwinding or degradation of already-formed hybrids by
helicases and RNase H enzymes, respectively. In eukaryotic cells,
DNA:RNA hybrids are degraded by RNase H1 and RNase H2, the
latter accounting for the majority of RNase H activity in mam-
malian nuclei. RNase H2 is a heterotrimeric complex composed
of a conserved catalytic subunit, called RNASEH2A, and auxiliary
subunits RNASEH2B and RNASEH2C32, which mediate the
interaction with other proteins. RNase H2, in addition to its role
in removing misincorporated ribonucleotides from genomic
DNA33,34, which have been recently described as a source of
PARP-trapping DNA lesions35, is also responsible for the reso-
lution of DNA:RNA hybrids generated by RNA pol II during
transcription36. Very recently, RNase H2 was also shown to
regulate DNA:RNA hybrid levels at telomeres37. Furthermore, a
physiologic role for human RNase H2 was uncovered through the
discovery that mutations in any of its subunits cause the
Aicardi–Goutieres syndrome, a neuroinﬂammatory disease asso-
ciated with the chronic activation of the immune system in
response to an excessive accumulation of aberrant forms of
nucleic acids38.
Strong links between HR proteins, RNA, and DNA:RNA
hybrids have already been demonstrated and continue to emerge:
BRCA1 interacts with several transcription and RNA-processing
factors including RNA pol II39,40, recognizes and promotes the
processing of miRNA precursors41, and mediates the recruitment
of the DNA/RNA helicase SENATAXIN to gene terminators to
avoid genome instability induced by DNA:RNA hybrid accu-
mulation42. Depletion of BRCA1 or BRCA2 results in the accu-
mulation of DNA:RNA hybrids globally43,44 and speciﬁcally at
promoter proximal sites of actively transcribed genes45,46. In
addition, proteins involved in the fanconi anemia (FA) repair
pathway are recruited to DNA damage sites via DNA:RNA
hybrids to suppress hybrid-associated genomic instability47,48.
Altogether these results suggest an emerging but yet undeﬁned
intimate relationship between DNA:RNA hybrids and the HR
repair pathway.
Herein, we explore the links between RNA, DNA:RNA hybrid
formation and metabolism, and HR. We show that dilncRNAs
generated at DSBs contribute to the recruitment of the HR pro-
teins BRCA1/BRCA2/RAD51 to DSBs. Speciﬁcally, in the S/G2
cell-cycle phase dilncRNAs pair to the resected DNA ends to
form DNA:RNA hybrids, which are directly recognized by
BRCA1. Moreover, we demonstrate that BRCA2 modulates DNA:
RNA hybrid levels at DSBs by interacting with and mediating
RNase H2 recruitment to DSBs. Combined, our data provide a
mechanistic model for the emerging interplay between DNA:
RNA hybrids and HR proteins.
Results
DNA:RNA hybrids form at DSBs. Recently, we reported that
RNA pol II is recruited to DSBs where it transcribes dilncRNAs
bidirectionally starting from exposed DNA ends17. In the same
experimental setup where dilncRNAs were characterized, we
investigated whether they could form DNA:RNA hybrids.
We induced a site-speciﬁc DSB by transfecting HeLa cells with
the I-PpoI nuclease, whose nuclear localization is induced by
4-hydroxytamoxifen (4-OHT). Upon I-PpoI-mediated DSB gen-
eration within the weakly transcribed DAB1 gene (Supplementary
Fig. 1a), we monitored the formation of DNA:RNA hybrids by
DNA:RNA hybrid immunoprecipitation (DRIP): brieﬂy, non-
crosslinked DNA:RNA hybrids were immunopuriﬁed with the
speciﬁc S9.6 monoclonal antibody and analyzed by quantitative
polymerase chain reaction (qPCR). We observed that DSB gen-
eration induces the formation of DNA:RNA hybrids peaking at
~1.5 kb and up to 3 kb from both sides of the DSB (Fig. 1a, b),
consistently with the already reported dilncRNAs generated upon
cutting17. Importantly, when cut samples were treated with
RNase H, levels of DNA:RNA hybrids strongly decreased,
demonstrating the speciﬁcity of the signal (Fig. 1b).
The accumulation of DNA:RNA hybrids at both sides of the
DSB resembled the RNA Pol II-mediated de novo bidirectional
transcription of dilncRNAs from the DSB17, suggesting that
dilncRNAs, rather than pre-existing RNA, such as a mRNA, are
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generating the observed hybrids (Fig. 1a). To further conﬁrm this
observation, we monitored DNA:RNA hybrid accumulation at a
DSB within a nongenic I-PpoI target site in HeLa cells
(Supplementary Fig. 1a). Indeed, DSB induction by I-PpoI led
to DNA:RNA hybrid accumulation also at this site (Fig. 1c), thus
supporting the notion that DSBs induce the synthesis of de novo
transcripts that form DNA:RNA hybrids at DSBs. In order to
extend this observation to another nongenic region generated in a
different cellular system in which DSBs are induced by a different
nuclease, we used DIvA (DSB inducible via AsiSI) U2OS cells
(Supplementary Fig. 1a), where nuclear localization of the AsiSI
restriction enzyme is induced by 4-OHT to generate DSBs at
distinct locations49 (Supplementary Fig. 1b, c). By DRIP-qPCR
analyses, we observed DNA:RNA hybrids accumulation at the
nongenic AsiSI-induced DSB analyzed (Fig. 1d). Consistently,
strand-speciﬁc reverse transcription followed by qPCR conﬁrmed
dilncRNA accumulation upon damage at this nongenic AsiSI
cleavage site (Supplementary Fig. 1d). Genome-wide accumula-
tion and distribution of DNA:RNA hybrids at AsiSI-induced
DSBs was recently investigated30. We further analyzed these
DRIP-seq data and matched them with sites of AsiSI-induced
DNA damage as determined in our laboratory by a high-
resolution and genome-wide DSB mapping method named
breaks labeling in situ and sequencing (BLISS)50. We analyzed
the accumulation and enrichment of DNA:RNA hybrids in
damaged compared to undamaged cells at efﬁciently cleaved
AsiSI sites, as judged by BLISS, at different windows of distance
from DSBs. This independent experiment and analysis
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Fig. 1 DNA:RNA hybrids form at DSBs independently of the genomic context. a Schematic representation of DNA:RNA hybrids (in red) that can be
generated upon the hybridization of mRNA (top) or dilncRNAs (bottom) with resected DNA ends at the I-PpoI cut site within DAB1 gene. b DRIP-qPCR
analysis at the I-PpoI cut site within a genic (DAB1 gene) or c nongenic locus in HeLa cells transfected with the I-PpoI nuclease. d DRIP-qPCR analysis at a
nongenic AsiSI cut site in DIvA cells. Bar graphs in b, c and d show fold induction of DNA:RNA hybrid levels in cut samples relative to uncut. RNase H
treatment was performed on cut samples to demonstrate speciﬁcity of the signal. Error bars represent s.e.m. (n≥ 3 independent experiments). *P < 0.05,
**P < 0.01 (two-tailed Student’s t test). e Boxplot representing log2 ratio of the fold change of DNA:RNA hybrid reads in cut compared to uncut samples at
the BLISS detected top 50 cut AsiSI sites at different distances from the DSBs. *P < 0.05, **P < 0.01 (Wilcoxon signed-rank test). Source data are provided
as a Source Data ﬁle
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reconﬁrmed the DNA:RNA hybrid accumulation proﬁle detected
by DRIP-qPCR for the nongenic AsiSI site analyzed in Fig. 1d,
shown as red dots in Fig. 1e. Most importantly, the analysis of the
most efﬁciently cut AsiSI sites in this dataset indicates at the
genome-wide level a general increase of DNA:RNA hybrid
accumulation starting at 0.5 kb from the DSB (Fig. 1e).
Additionally, DNA:RNA hybrid enrichment was observed both
at DSBs located within genic and nongenic regions (Supplemen-
tary Fig. 1e), suggesting that DNA:RNA hybrids accumulate at
sites of DNA damage independently from their transcribed or
untranscribed status before DSB induction.
Since dilncRNAs production is dependent on RNA pol II17,18,
we tested whether RNA pol II inhibition with 5,6-dichloro-1-β-
D-ribofuranosylbenzimidazole (DRB) affected DNA:RNA hybrid
generation. DRIP-qPCR at the I-PpoI cleavage site within the
DAB1 gene in HeLa cells treated with DRB, or with vehicle only,
prior to DSB induction, revealed that DNA:RNA hybrid
accumulation at the damaged site is dependent on RNA pol II
(Supplementary Fig. 1f).
Collectively, these results show that DNA:RNA hybrids form at
DSBs, as independently demonstrated site-speciﬁcally and
genome-wide by DRIP analyses at genic and nongenic loci, and
that their accumulation requires RNA pol II activity.
DSB-induced DNA:RNA hybrids form at resected DNA ends.
Having demonstrated that DNA:RNA hybrids accumulate at I-
PpoI- and AsiSI-induced DSBs regardless of the genomic location
and that their formation requires RNA pol II activity, we rea-
soned that, during the S/G2 cell-cycle phase, DNA-end resection
and consequent single-stranded DNA generation could provide a
suitable DNA substrate for dilncRNA pairing to their resected
template DNA and allow hybrids to form (Fig. 1a). We therefore
tested whether DNA:RNA hybrid formation is modulated during
the cell-cycle by using HeLa-FUCCI cells, which express the
ﬂuorescent ubiquitination-based cell-cycle indicators (FUCCI)51.
Following I-PpoI expression, we sorted cells into G1- and S/G2-
phase populations and we monitored DNA:RNA hybrid levels by
DRIP-qPCR. Importantly, DNA:RNA hybrid accumulation was
analyzed at 1.5 kb on the right from the I-PpoI-induced DSB
within the DAB1 gene, where the resected DNA end could pair
only with the newly synthesized dilncRNA and not with a
potentially pre-existing mRNA (Fig. 1a). We observed that, upon
DSB induction, DNA:RNA hybrids accumulate preferentially in
the S/G2-phase of the cell-cycle (Fig. 2a).
We next aimed to extend our observations to DSBs formed
throughout the genome by an independent approach. To that
end, we utilized super-resolution ﬂuorescence microscopy
(STORM) and analyzed U2OS cells synchronized in G1- or S-
phase and treated with the radiomimetic drug neocarzinostatin
(NCS). We determined the extent of colocalization between the
DDR marker γH2AX and DNA:RNA hybrids detected by the S9.6
antibody by quantifying the overlaps of their signals in each cell
relative to the calculated number of overlaps present due to
random distribution52,53. Importantly, the wider distribution of
γH2AX compared to DNA:RNA hybrids was also accounted for
in our analysis by this approach. We observed increased rates of
colocalization between γH2AX and DNA:RNA hybrids in S-
compared to G1-phase cells (Fig. 2b, c).
Given the preferential DNA:RNA hybrid accumulation at DSBs
in the S/G2 cell-cycle phase, we tested the contribution of DNA-
end resection to their formation. To this aim, we knocked-down
EXO1 or CtIP and we monitored DNA:RNA hybrid levels by
DRIP-qPCR at 1.5 kb on the right from the I-PpoI cleavage site
within DAB1 gene, as above. We observed that inhibiting
resection by knocking-down EXO1 (Supplementary Fig. 2a, b)
impairs DNA:RNA hybrid accumulation (Fig. 2d), while not
affecting dilncRNA transcription (Fig. 2e). Knock-down of CtIP,
which is required for MRN functions at DSBs, among which
initiation of DNA-end resection (Supplementary Fig. 2c, d),
reduces DNA:RNA hybrid (Fig. 2f) as well as dilncRNA levels
(Fig. 2g), in line with the reported function of MRN in
modulating dilncRNAs transcription17. In conclusion, while CtIP
is required for dilncRNA transcription, probably by favouring
other MRN functions rather than DNA-end resection, DNA-end
resection per se, as shown by EXO1 knock-down, seems not to be
required for dilncRNA transcription but it only provides available
templates for dilncRNAs hybridization and, therefore, DNA:RNA
hybrid formation. As a control, neither CtIP nor EXO1 knock-
down altered cell-cycle phase distribution (Supplementary
Fig. 2e).
Having observed that DNA:RNA hybrids accumulation occurs
downstream of DNA-end resection, we aimed at monitoring the
impact on transcriptional inhibition on DNA-end resection. In
order to test this, we speciﬁcally and acutely inhibited RNA pol II
activity with α-amanitin or DRB and we simultaneously
irradiated (5 Gy) HeLa cells—effective RNA pol II inhibition
was conﬁrmed by monitoring by RT-qPCR c-FOS mRNA level, a
speciﬁc RNA pol II transcript with a short half-life (Supplemen-
tary Fig. 3a, b). DNA-end resection was measured by immuno-
ﬂuorescence analyses of exposed ssDNA through native staining
of incorporated BrdU, total RPA and its phosphorylated form
(RPA2 pS4/8)—focal signals were quantiﬁed in S/G2 cells, as
monitored by the S/G2 phase marker cyclin A. Consistently, all
three markers revealed proﬁcient DNA-end resection upon RNA
pol II inhibition (Fig. 3a, b and Supplementary Fig. 3c), in line
with the observed DNA:RNA hybrids accumulation downstream
of DNA-end resection.
Overall, these data show that DNA:RNA hybrid formation
occurs preferentially during the S/G2 cell-cycle phases and it is
facilitated by DNA-end resection.
dilncRNAs contribute to HR-mediated repair. We next studied
the impact of transcriptional inhibition on the focal accumulation
of HR proteins, which are speciﬁcally recruited to DSBs in the S/
G2 cell-cycle phase. We inhibited RNA pol II activity with α-
amanitin or DRB and we simultaneously irradiated (5 Gy) HeLa
cells, as described above. We observed that both treatments sig-
niﬁcantly impair the formation of BRCA1, BRCA2, and RAD51
foci (Fig. 3c, d and Supplementary Fig. 3d), despite unaltered
overall protein levels (Supplementary Fig. 3e, f).
We next sought to test a direct role of dilncRNAs in HR
downstream of DNA-end resection. For this, we employed the DR-
GFP reporter cell system54 in which HR between a mutated
integrated GFP construct, containing the I-SceI recognition site, and
a truncated GFP generates a functional GFP open reading frame
(Supplementary Fig. 4a). Following I-SceI induction, HR can be
monitored by either the evaluation of GFP expression by
ﬂuorescence-activated cell sorting (FACS) analysis in individual
cells or, more directly but in bulk, by PCR ampliﬁcation of the
recombined genomic DNA sequence. We impaired dilncRNAs
functions by complementary antisense oligonucleotides (ASOs)
(Supplementary Fig. 4a)—ASOs are modiﬁed oligonucleotide
widely used to inhibit the function of their target RNAs55 and
have been previously used by our group to target dilncRNAs and
inhibit DDR17,18. We transfected different sets of ASOs comple-
mentary to the predicted dilncRNAs generated at the I-SceI locus
and simultaneously induced I-SceI for 72 h. Both FACS analysis of
GFP expression (Fig. 3e) and PCR to detect the recombined
genomic locus (Fig. 3f) demonstrated that ASOs matching
dilncRNAs reduce HR efﬁciency, while an ASO matching an
unrelated sequence (CTRL) had no impact on HR (Fig. 3e, f).
Importantly, the same ASOs inactivated by annealing with
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complementary sequences (Inactive) did not inhibit HR and all the
ASOs left cell-cycle unaltered (Supplementary Fig. 4b). In this same
cell system, genomic PCR can also be used to study SSA, a RAD52-
dependent but RAD51-independent mechanism that shares with
HR the initial DNA-end resection step. We observed that ASOs do
not inhibit SSA (Fig. 3g), further indicating that dilncRNA
inactivation impacts the HR process downstream of DNA-end
resection. The impact of ASO-mediated dilncRNA inactivation on
HR was further assessed using a different reporter system, the trafﬁc
light reporter (TLR) system, that allows monitoring of both HR
(GFP-positive cells) and mutagenic NHEJ (mCherry positive cells)
events (Supplementary Fig. 4c)56. In this system, we conﬁrmed that
ASO-mediated dilncRNA inactivation reduces HR and we also
observed an impairment of mutNHEJ, as monitored by FACS
analysis of the percentage of GFP and mCherry positive cells,
respectively (Supplementary Fig. 4d). Importantly, treatment with
ASOs did not cause signiﬁcant cell-cycle alterations (Supplementary
Fig. 4e).
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These results show that BRCA1, BRCA2, and RAD51 focal
accumulation to DSBs is reduced upon transcriptional inhibition
and that ASOs-mediated dilncRNAs inactivation impairs HR.
DNA:RNA hybrids are directly recognized by BRCA1. Based on
our observations that dilncRNAs form DNA:RNA hybrids in S/
G2-phase cells and modulate the recruitment of HR proteins to
sites of DNA damage, we sought to test the contribution of DNA:
RNA hybrids to the focal accumulation of HR proteins at DSBs.
By performing super-resolution imaging and analyzing the extent
of colocalization between BRCA1 and DNA:RNA hybrids in
NCS-treated U2OS cells synchronized in S-phase, we observed
that the few detectable DNA:RNA hybrids often co-localize with
BRCA1 in S-phase cells upon damage (Fig. 4a, b).
To test whether BRCA1 can directly recognize DNA:RNA
hybrids, we used puriﬁed recombinant human BRCA1 or the
constitutive BRCA1-BARD1 heterodimer in an electrophoretic
mobility shift assay (EMSA) with either DNA duplexes or DNA:
RNA hybrids. Radioactively labeled probes were incubated with
the recombinant proteins and separated by electrophoresis on a
native polyacrylamide gel. Both BRCA1 alone and BRCA1-
BARD1 bound the DNA:RNA hybrid, with an afﬁnity compar-
able to that for dsDNA (Fig. 4c, d). BRCA1-BARD1 binding with
DNA:RNA hybrids, as well as dsDNA, was resistant to increasing
salts concentrations, suggesting a robust binding (Supplementary
Fig. 5a). Additionally, we performed competitive EMSA in which
we prebound BRCA1-BARD1 with either labeled dsDNA or
DNA:RNA hybrids and we then challenged the interaction with
unlabeled DNA:RNA hybrids or dsDNA, respectively. In this
experimental setup, we observed a modest preference for binding
to hybrids, as opposed to dsDNA (Supplementary Fig. 5b).
Having observed that BRCA1 can bind DNA:RNA hybrids, we
tested whether the modulation of DNA:RNA hybrid level at DSBs
in living cells impacted on BRCA1 focal accumulation and/or
retention at DSBs. To this purpose, we monitored BRCA1 foci
formation at DSBs in irradiated (2 Gy) U2OS cells expressing
RNase H1 fused to GFP, or GFP alone as a control. We observed
that RNase H1 overexpression impairs ionizing radiation-induced
BRCA1 foci formation (Fig. 4e, f), indicating a role for DNA:RNA
hybrids in favouring BRCA1 recruitment and/or retention to
DSBs. To rule out any indirect effect of RNase H1 overexpression,
we treated irradiated cells with RNase H in situ. Brieﬂy, we
irradiated U2OS cells (2 Gy) and 1 h later we gently permeabi-
lized and incubated them with recombinant bacterial RNase H.
After 30 min, cells were ﬁxed and BRCA1 foci were monitored in
S/G2-phase cells. We observed that RNase H treatment reduces
the amount of BRCA1 foci (Fig. 4g, h), while not impacting
neither on the number of γ-H2AX foci (Supplementary Fig. 5c),
nor on DNA-end resection, as determined by RPA foci
(Supplementary Fig. 5d).
These results show that DNA:RNA hybrids can be directly
recognized by BRCA1 in vitro and in living cells.
RNase H2 is recruited to DSBs in the S/G2 cell-cycle phase. The
observation that excessive DNA:RNA hybrid accumulation may be
detrimental for HR29 could suggest that their levels at DSBs need to
be tightly controlled. Since RNase H2 is the major source of RNase
H activity in mammalian nuclei57, we tested its recruitment to DSBs
by performing chromatin immunoprecipitation (ChIP) and assay-
ing for RNASEH2A enrichment at the nongenic AsiSI cut site in
DIvA cells in which we described DNA:RNA hybrid accumulation
upon DSB formation. We observed enrichment of RNASEH2A,
and of γH2AX as a control, at the AsiSI cleavage site in cut relative
to uncut cells (Fig. 5a and Supplementary Fig. 6a). To further
validate this result with a different technique and at multiple
genomic sites, we performed immunoﬂuorescence microscopy to
detect RNase H2 in irradiated or not irradiated cells. However, such
stainings showed a diffuse signal that failed to reveal discrete foci
under the conditions tested (Supplementary Fig. 6b). To increase
the sensitivity and speciﬁcity of the signal, we performed proximity
ligation assay (PLA) between RNASEH2A and γH2AX in not
irradiated or irradiated (2 Gy) U2OS cells ﬁxed 1 or 6 h after irra-
diation. We observed an increase in PLA signals between RNA-
SEH2A and γH2AX in irradiated cells (Fig. 5b, c), thus suggesting
that the two proteins become in close proximity upon irradiation.
As a negative control, no signal was detected when only one of the
two primary antibodies was used (Supplementary Fig. 6c) and, as a
reference, a comparable PLA signal was observed between γH2AX
and the HR marker RAD51 (Supplementary Fig. 6d). Since
damage-induced DNA:RNA hybrids preferentially accumulate in
the S/G2 cell-cycle phase, we monitored RNase H2 recruitment to
DSBs in irradiated (2 Gy) and not irradiated HeLa-FUCCI cells. In
this setup, we observed an increase in PLA signals between γH2AX
and RNASEH2A in S/G2-phase irradiated cells compared to irra-
diated G1 or to S/G2 not irradiated cells (Fig. 5d, e), indicating that
RNase H2 localizes to DSBs preferentially in the S/G2 cell-cycle
phase. Similar results were obtained with a different antibody raised
against RNASEH2A (Supplementary Fig. 6e) or the RNASEH2B
subunit (Supplementary Fig. 6f). These conclusions were not biased
by cell-cycle variations of γH2AX foci or of RNase H2 protein
levels, as both the number of γH2AX foci (Supplementary Fig. 6g)
and the RNASEH2A and RNASEH2B pan-nuclear signals (Sup-
plementary Fig. 6h, i) remained unchanged in G1- versus S/G2-
phase cells. The observed increased PLA signal in S/G2- compared
to G1-phase cells, with unaltered levels of both antigens, further
demonstrates the speciﬁcity of the assay and of the conclusions
reached. In line with the S/G2-phase recruitment of RNase H2 to
DSBs, we observed increased PLA signals between RNASEH2A and
RPA upon ionizing radiation (Supplementary Fig. 6j), while no
changes upon DNA damage induction were observed when PLA
was performed between BRCA2 and RNASEH2A (Supplementary
Fig. 6k), suggesting a potentially constitutive interaction between
Fig. 2 DSB-induced DNA:RNA hybrids form at resected DNA ends in S/G2-phase cells. a DRIP-qPCR analysis at 1.5 kb on the right from the I-PpoI cut site
within DAB1 gene in G1- or S/G2-phase-sorted HeLa-FUCCI cells transfected with the I-PpoI nuclease. The bar graph shows fold induction of DNA:RNA
hybrid levels in cut samples relative to uncut. Error bars represent s.e.m. (n= 3 independent experiments). b Representative pictures of super-resolution
imaging analysis of γH2AX (cyan) and DNA:RNA hybrids (yellow) colocalization in S-phase synchronized U2OS cells treated with neocarzinostatin (NCS).
Scale bar: 5 μm. c Dot plot shows the normalized number of overlaps relative to random of γH2AX and DNA:RNA hybrids signals in G1- or S-phase NCS-
treated U2OS cells. At least n= 60 events were counted from three independent experiments. Lines represent mean ± s.e.m. d DRIP-qPCR analysis at 1.5
kb on the right from the I-PpoI cut site within DAB1 gene in cells knocked-down for EXO1. Error bars represent s.e.m. (n= 3 independent experiments).
e Strand-speciﬁc RT–qPCR analysis of dilncRNAs levels at 1.5 kb on the right from the I-PpoI cut site within DAB1 gene in cells knocked-down for EXO1.
Error bars represent s.e.m. (n= 4 independent experiments). f DRIP-qPCR analysis at 1.5 kb on the right from the I-PpoI cut site within DAB1 gene in cells
knocked-down for CtIP at different time points after cut induction. Error bars represent s.e.m. (n= 5 independent experiments). g Strand-speciﬁc RT-qPCR
analysis of dilncRNAs levels at 1.5 kb on the right from the I-PpoI cut site within DAB1 gene in cells knocked-down for CtIP at different time points after cut
induction (n= 2 independent experiments). *P < 0.05, **P < 0.01, ****P < 0.0001 (two-tailed Student’s t test). Source data are provided as a Source Data ﬁle
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these two proteins. As a negative control, PLA between RNA-
SEH2A and the centromeric protein B generated a very low signal,
which did not increase upon DNA damage induction (Supple-
mentary Fig. 6l).
In order to further extend our observations with an
independent approach, we performed super-resolution imaging
analysis of γH2AX and RNASEH2A colocalization in U2OS cells
treated with NCS and we measured the extent of colocalization
relative to random events. In agreement with PLA results, we
observed that RNase H2 co-localizes with γH2AX in NCS-treated
S-phase cells (Fig. 5f, g).
Overall, these results consistently indicate that RNase H2 is
recruited to DSBs, both induced at a speciﬁc locus and genome-
wide, preferentially during the S/G2 phase of the cell-cycle.
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BRCA2 and RNase H2 control DNA:RNA hybrid levels at
DSBs. Published reports suggest BRCA2 as a possible regulator of
the cellular levels of DNA:RNA hybrids43,46. To test whether
DNA:RNA hybrid levels at DSBs could be controlled by BRCA2
through RNase H2 recruitment, we monitored by super-
resolution microscopy the colocalization of γH2AX and RNA-
SEH2A in S-phase synchronized cells knocked-down for BRCA2
and treated with NCS. We observed that BRCA2 knock-down
strongly reduces the colocalization of γH2AX and RNASEH2A
(Fig. 6a). The same results were conﬁrmed by PLA between
γH2AX and RNASEH2A in S/G2-phase irradiated (2 Gy) HeLa-
FUCCI cells knocked-down for BRCA2, which revealed reduced
RNASEH2A recruitment to DSBs in the absence of BRCA2
(Fig. 6b and Supplementary Fig. 7a–c) despite no signiﬁcant
differences in the number of γH2AX foci (Supplementary
Fig. 7d). The observed requirement of BRCA2 for RNase H2
recruitment to DSBs prompted us to test whether the two pro-
teins could form a complex. We thus performed immunopreci-
pitation experiments from cell lysates of irradiated and not
irradiated HEK293T cells prepared in the presence of benzonase
to degrade all contaminating nucleic acids. We observed that
RNASEH2A co-immunoprecipitates with BRCA2 and other
proteins of the HR machinery, including BRCA1, PALB2, and
RAD51, independently of DNA damage induction (Fig. 6c). This
interaction is speciﬁc within this complex since no interactions
with proteins known to be part of other BRCA1 complexes, such
as CtIP and RAP80, were observed (Supplementary Fig. 7e).
Having observed that BRCA2 is in a complex with and controls
RNase H2 recruitment to DSBs, we tested whether the two pro-
teins directly interact by performing pull-down experiments with
a set of 9 puriﬁed recombinant GST-tagged BRCA2 fragments
spanning its entire length58 with recombinant puriﬁed RNase H2
complex. We observed that BRCA2 and RNase H2 directly
interact through the BRC-containing region of BRCA2 (Fig. 6d).
To additionally identify with more precision whether and which
of the individual(s) BRC-repeats directly interact with RNase H2,
we performed a pull-down of the 8 biotinylated BRC-peptides
with the recombinant RNase H2 and we determined a speciﬁc
interaction with BRC repeat 1 and 3 (Fig. 6e).
In order to test whether the impaired RNase H2 localization to
DSBs upon BRCA2 inactivation resulted in increased DNA:RNA
hybrid levels at DSBs, we monitored by super-resolution
microscopy the colocalization of γH2AX and DNA:RNA hybrids
in S-phase synchronized cells knocked-down for BRCA2 and
treated with NCS. We observed that BRCA2 knock-down further
increases the DNA:RNA hybrid signals at γH2AX foci (Fig. 6f).
The same results were conﬁrmed by DRIP-qPCR at the I-PpoI
site within the DAB1 gene in S/G2-phase-sorted HeLa-FUCCI
cells knocked-down for BRCA2—sorting of the S/G2-phase cells
population was necessary since BRCA2 inactivation affects the
cell-cycle. DRIP-qPCR analysis revealed a signiﬁcantly increased
accumulation of DNA:RNA hybrids at the DSB in the absence of
BRCA2 (Fig. 6g and Supplementary Fig. 7a), indicating that
BRCA2, likely via the recruitment of RNase H2, regulates DNA:
RNA hybrid levels at DSBs. Interestingly, RAD51 knock-down in
the same experimental conditions did not signiﬁcantly alter DNA:
RNA hybrid levels at the tested DSB (Supplementary Fig. 7a, f).
Altogether, these results show that BRCA2 directly interacts
with RNase H2 and controls DNA:RNA hybrid levels at DSBs by
mediating RNase H2 recruitment.
Finally, to determine the sequence of events at DSBs, we
performed a series of ChIP to generate a time-course analysis of the
recruitment of RNase H2 and key HR factors to DSB. To this end,
we induced AsiSI cleavage in DIvA cells and we collected cells 2, 4,
6, and 8 h after DSB induction. We observed that γH2AX and
BRCA1 signals are detectable already at early time points after DSB
formation and are maintained throughout time points analyzed
(Fig. 7a, b and Supplementary Fig. 7g, h). DNA-end resection, as
monitored by RPA enrichment (Fig. 7c and Supplementary Fig. 7i),
and BRCA2 recruitment (Fig. 7d and Supplementary Fig. 7j) were
detectable 4 h upon DSB formation, followed by RNase H2 (Fig. 7e
and Supplementary Fig. 7k) and RAD51 (Fig. 7f and Supplementary
Fig. 7l), peaking at 6 and 8 h, respectively.
Together, these data support a model in which RNase H2
recruitment to DSBs is mediated by BRCA2 and is followed by
RAD51 ﬁlament formation (Fig. 7g).
Discussion
We have recently demonstrated that in mammalian cells RNA pol
II is recruited to exposed DNA ends upon breakage, where it
bidirectionally transcribes RNA species named dilncRNAs17. In
the present study, we show that dilncRNAs form DNA:RNA
hybrids downstream of DNA-end resection, upon hybridization
with resected DNA ends, and contribute to HR. DSB-induced
DNA:RNA hybrids are recognized by BRCA1 and their levels are
modulated by BRCA2-mediated RNase H2 recruitment to DSBs.
Our observation that DNA:RNA hybrids form at DSBs in
mammalian cells is in line with recent data in S. pombe and
mammalian cells showing DNA:RNA hybrid accumulation at
DSBs27,28,30,31 and with the observed localization of the human
RNA-unwinding protein DEAD box 1 (DDX1)29 and the DNA/
RNA helicase SENATAXIN30,59 to DSBs in a transcription- and
DNA:RNA hybrids-dependent manner. Importantly, we
demonstrate that DNA:RNA hybrids form at DSBs in both genic
and nongenic regions, in line with the observed DNA:RNA
hybrid accumulation in regions both transcriptionally active and
inactive prior to DNA damage induction30, thus suggesting that
newly transcribed dilncRNA could contribute to DNA:RNA
hybrids formation. Further supporting this observation, we also
demonstrate that the presence of resected DNA ends is required
for DNA:RNA hybrids accumulation at DSBs. This indicates that
DNA:RNA hybrid formation, even in genic regions, cannot only
be the result of pairing of the pre-existing mRNA to the template
DNA, since it would occur only on one side of the DSB: the one
with exposed ssDNA matching the pre-existing transcript (see
Fig. 1a). Conversely, the observed DNA:RNA hybrid accumula-
tion at both sides of DSBs is compatible with newly
Fig. 3 dilncRNAs contribute to HR proteins recruitment to DSBs and HR-mediated repair. a Representative images of DNA-end resection markers: ssDNA
(visualized by BrdU native staining), RPA2, and RPA2 pS4/8 foci, co-stained with cyclin A, as S/G2-phase marker, in irradiated (5 Gy) HeLa cells treated
with H2O or α-amanitin. Scale bar: 10 μm. b Dot plots show the number of signals/foci in a. At least n= 60 cells were counted from three independent
experiments. Lines represent mean ± s.e.m. c Representative images of BRCA1, BRCA2, and RAD51 foci co-stained with cyclin A or CENPF, as S/G2-phase
markers, in irradiated (5 Gy) HeLa cells treated with H2O or α-amanitin. Scale bar: 10 μm. d Dot plots show the number of foci in c. At least n= 120 cells
were counted from three independent experiments. Lines represent mean ± s.e.m. e–g DR-GFP cells are treated with control ASO (CTRL), ASOs matching
dilncRNAs (A/B), or inactive ASOs. e HR efﬁciency is monitored by FACS analysis of the percentage of GFP-positive cells or f by genomic semiquantitative
PCR with primers P1 and P2 that only amplify the recombined GFP sequence generated after HR (see Supplementary Fig. 4a). g SSA efﬁciency is assessed
by monitoring the 0.8 kb amplicon generated by genomic semiquantitative PCR with primers F1 and R2 (see Supplementary Fig. 4a). Bar graphs show the
mean of n≥ 2 independent experiments. Error bars represent s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (two-tailed Student’s t test). Source
data are provided as a Source Data ﬁle
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07799-2
8 NATURE COMMUNICATIONS |          (2018) 9:5376 | https://doi.org/10.1038/s41467-018-07799-2 | www.nature.com/naturecommunications
DNA:RNA hybrids
BRCA1
DNA:RNA hybrids BRCA1a
1500 30 60 100 150 0 30 60 100
BRCA1-BARD1
DNA:DNA
*
DNA:RNA
*
BRCA1
1500 30 60nM: 100 150 0 30 60 100
BRCA1-BARD1BRCA1
DMSO NCS
0.5
1.0
1.5
2.0
N
or
m
al
iz
ed
 n
um
be
r o
f 
BR
CA
1-
DN
A:
RN
A 
hy
br
id
s 
o
ve
rla
ps
 re
la
tiv
e 
to
 ra
nd
om
**
b
c
0 50 100 150
0
25
50
75
100
nM Protein
%
 S
ub
st
ra
te
 b
ou
nd BRCA1 DNA
BRCA1-BARD1 DNA
BRCA1 DNA:RNA
BRCA1-BARD1 DNA:RNAd
0
Time post IR : 1 h 3 h 6 h
50
100
150
n
 o
f B
RC
A1
 fo
ci
pe
r S
/G
2 
nu
cle
us
** * ****
CTRL RNase H
0
5
10
15
20 ****
n
 o
f B
RC
A1
 fo
ci
pe
r S
/G
2 
nu
cle
us
GFP
GFP-RH1
Cyclin ABRCA1
Cyclin ABRCA1 GFP
G
FP
G
FP
G
FP
G
FP
-R
H1
G
FP
-R
H1
G
FP
-R
H1
CT
RL
R
N
as
e 
H
2G
y 
1 
h
2G
y 
3 
h
2G
y 
6 
h
e f
g h
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bidirectionally transcribed dilncRNAs pairing with their template
resected DNA ends. The DNA:RNA hybrids formation down-
stream of DNA-end resection is consistent with data generated in
S. pombe27 and with the observed requirement of DNA-end
resection for the DNA:RNA hybrid-dependent recruitment of
DDX129. Interestingly, the reported need for pre-existing tran-
scription to promote RNA-mediated repair in Saccharomyces
cerevisiae60 is consistent with the reported lack of recruitment of
RNA polymerase II to DSBs and the lack of transcriptional
induction in this species61.
Our work also shows that transcriptional inhibition, while not
reducing DNA-end resection, impairs the focal accumulation of
the HR proteins BRCA1, BRCA2, and RAD51 at DSBs. Impor-
tantly, the speciﬁcity of the RNA Pol II inhibitors used (α-ama-
nitin and DRB) makes unlikely the contribution of other RNA
synthetizing enzymes to this process. In line with the reduced
focal accumulation of HR proteins at DSBs upon RNA pol II
inhibition, site-speciﬁc inactivation of dilncRNAs by com-
plementary ASOs inhibits repair by HR, but does not affect SSA,
which requires extensive DNA-end resection but differs from HR
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in the subsequent steps. The observation that transcriptional
inhibition does not reduce DNA-end resection while impairing
BRCA1 foci formation can be explained by the concomitant
reduction of 53BP1 foci formation upon transcriptional inhibi-
tion or ASO treatment17, which is also consistent with the
observed reduction in NHEJ efﬁciency upon ASOs-mediated
dilncRNAs inactivation. Indeed, since BRCA1 is required to
oppose the inhibitory effect of 53BP1 on DNA-end resection, in
the absence of 53BP1, as upon RNA pol II inhibition or ASO
treatment, BRCA1 may become dispensable for this process15.
This could also explain the observed stronger impact of tran-
scriptional inhibition on BRCA1 recruitment to DSBs compared
to BRCA2 and RAD51. Notably, the moderate increase of DNA-
end resection observed upon transcriptional inhibition may be
caused either by a higher efﬁciency of the resection process, or,
more intriguingly and consistent with our model, by an increased
availability of single-stranded DNA for RPA binding in the
absence of a competing complementary RNA paired to the
resected DNA end.
At DSBs BRCA1 can be detected co-localizing with DNA:RNA
hybrids, which seem to contribute to its focal accumulation and/
or its retention at DSBs. In particular, we also provide the ﬁrst
direct evidence that both the puriﬁed recombinant human
BRCA1 and the constitutive BRCA1-BARD1 heterodimer can
bind DNA:RNA hybrids in vitro, with an afﬁnity similar to the
dsDNA substrate. Additionally, the observation that dsDNA and
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DNA:RNA hybrids compete for BRCA1-BARD1 binding suggests
that both nucleic acids structures share the same binding site.
This result provides evidence in support of a direct interaction
between BRCA1 and DNA:RNA hybrids and it is consistent with
the observed DNA:RNA hybrid-dependent BRCA1 recruitment
to gene termination sites in living cells42.
Recent evidence shows that excessive amounts of DNA:RNA
hybrids at DSBs may dampen repair by HR, as demonstrated by
impaired HR efﬁciency in the absence of the RNA-unwinding
protein DDX129 or SENATAXIN30. In line with these results, in
human and Drosophila cells, the catalytic component of the RNA
exosome, which contributes to RNA degradation, localizes to
DSBs and its activity is required for RAD51 loading62. In S.
pombe, only controlled levels of DNA:RNA hybrids at DSBs
facilitate repair27. Similarly, a precise level of DNA:RNA hybrids
is required to guarantee the proper length of mammalian telo-
meres that elongate through an HR-based pathway named
alternative lengthening of telomeres63. In mammalian cells,
emerging links between HR proteins and DNA:RNA hybrids have
recently been described and support our conclusions. DNA:RNA
hybrids accumulate globally in cells lacking BRCA1 or
BRCA243,44. Additionally, proteins that, together with BRCA2,
control the FA repair pathway localize to DNA damage sites via
DNA:RNA hybrids47,48. At promoter regions, accumulation of
DNA:RNA hybrids in BRCA2-deﬁcient cells is due to reduced
recruitment of RNA Pol II-associated factor 1 (PAF1), which
promotes RNA Pol II release46. However, until now, no
mechanisms explaining the emerging link between proteins
controlling HR and DNA:RNA hybrid metabolism at DSBs have
been proposed. Here, we provide the ﬁrst evidence that RNase
H2, the main protein responsible for DNA:RNA hybrid degra-
dation in mammalian nuclei57 localizes to DSBs during the S/G2
phase of the cell-cycle by directly interacting with BRCA2.
Indeed, BRCA2 knock-down reduces RNase H2 recruitment
while boosting DNA:RNA hybrid accumulation at DSBs. This
observation is not only consistent, but it could help mechan-
istically explaining the increased DNA:RNA hybrid levels
observed in BRCA2-depleted cells by others43.
In summary, we propose a model (Fig. 7g) in which DNA:RNA
hybrids form downstream of DNA-end resection, upon hybridi-
zation of dilncRNAs with resected DNA ends generated during
the S/G2 cell-cycle phase. DNA:RNA hybrids are initially recog-
nized by BRCA1 and, subsequently, BRCA2-mediated recruit-
ment of RNase H2 induces their degradation, thus ensuring
efﬁcient HR-mediated repair.
Methods
Cell culture. All the cell lines were grown under standard tissue culture conditions
(37 °C, 5% CO2). HeLa (ATCC, CCL-2) were grown in Minimum Essential
Medium (MEM) (Biowest/Gibco) supplemented with 10% fetal bovine serum
(FBS), 1% L-glutamine, nonessential amino acids (10 mM for each aa) and 1 mM
sodium pyruvate; U2OS cells (ATCC, HTB-96) were grown in McCoy’s 5A glu-
taMax (Gibco) supplemented with 10% FBS. HeLa-FUCCI (RIKEN BioResource
Center cell bank)51 and doxycycline-inducible I-SceI/DR-GFP (TRI-DR-U2OS)
(kind gift from P. Oberdoerffer) were cultured in Dulbecco’s Modiﬁed Eagle’s
medium (DMEM) (Lonza) supplemented with 10% FBS, 1% L-glutamine. For TRI-
DR-U2OS cells, I-SceI expression was induced by adding 5 μg/ml doxycycline to
the cell medium for 72 h. HEK293 TLRsce cells (kind gift from A.M. Scharenberg)
were cultured in DMEM (Lonza) supplemented with 10% FBS, 1% L-glutamine,
and 1 μg/ml puromycin. DIvA cells (AsiSI-ER-U20S) (kind gift from G. Legube)
were cultured in DMEM without phenol red (Gibco) supplemented with 10% FBS,
1% L-glutamine, 1% pyruvate, 2.5% HEPES, and 1 μg/ml puromycin. AsiSI-
dependent DSBs induction was obtained by treating the cells with 300 nM 4-
hydroxytamoxifen (4-OHT) (Sigma-Aldrich) for 4 h.
U2OS cell synchronization for super-resolution imaging experiments was
obtained by serum starvation. Brieﬂy, cells were plated on glass coverslips for 24 h.
G0/G1-phase synchronization was achieved by replacing complete medium with
serum-free medium for 72 h. A mid-S phase cell population was obtained after 16 h
release into complete medium. Double-strand breaks (DSBs) were generated by
using the radiomimetic drug Neocarzinostatin (NCS) (Sigma-Aldrich).
All cell lines are tested for mycoplasma by PCR and by a biochemical test
(MycoAlert, Lonza).
Ionizing radiation was induced by a high-voltage X-ray generator tube
(Faxitron X-Ray Corporation).
Transfections. Two micrograms of GFP-RNase H1 plasmid (kind gift from N.
Proudfoot) and its related control was transfected with Lipofectamine 2000 (Life
Technologies) and experiments were performed 24 h after transfection.
One microgram of mammalian ER-I-PpoI (kind gift from M. Kastan) was
transfected with Lipofectamine 2000. After 24 h transfection, nuclear translocation
of ER-I-PpoI was induced by adding 4-OHT (Sigma-Aldrich) at 2 μM ﬁnal
concentration for the indicated time. When I-PpoI was transfected, medium
without phenol red was used to avoid leakiness in the expression of the plasmid.
RNA interference was achieved by transfecting 5–20 nM siRNAs with
Lipofectamine RNAiMAX transfection reagent (Life Technologies) for 48 h. For
DNA:RNA hybrids detection upon EXO1, BRCA2, or RAD51 knock-down, cells
were seeded and transfected with siRNAs in parallel. I-PpoI was transfected the day
after. For DNA:RNA hybrids detection upon CtIP knock-down, cells were
transfected with siCtIP for 48 h, then replated and transfected with I-PpoI. After
24 h, I-PpoI expression was induced by 4-OHT. Sequences of the siRNA used are
listed in Supplementary Data 1.
For the DR-GFP experiments, TRI-DR-U2OS cells were transfected with a pool
of antisense oligonucleotides (ASOs) (A1–A5 and B1–B5), which are mixmers
containing locked nucleic acid oligonucleotides with a fully phosphorothioate
backbone (Exiqon), at 20 nM ﬁnal concentration using Lipofectamine RNAiMAX
transfection reagent (Life Technologies). Concomitantly with ASOs transfection, I-
SceI expression was induced by adding doxycycline to the cell media and HR was
evaluated 72 h after, as described in the section “DR-GFP and TLR reporter assay”.
For the TLR experiments, HEK293 TLRsce cells (kind gift from A. Scharenberg)
were transfected overnight with a pool of ASOs (A2–A4 and B2–B4) at a 50 nM
ﬁnal concentration together with the IFP-tagged I-SceI (0.75 μg) and the BFP-
tagged donor GFP template (0.75 μg) using Lipofectamine 2000 (Life
Technologies). The IFP-tagged I-SceI, pRRL sEF1a HA.NLS.Sce(opt).T2A.IFP
(Addgene plasmid # 31484), and the BFP-tagged GFP donor, pRRL SFFV d20GFP.
T2A.mTagBFP Donor (Addgene plasmid # 31485), were a gift from A.
Scharenberg56. The day after, medium containing the transfection reagents was
Fig. 6 BRCA2 controls DNA:RNA hybrid levels at DSBs by interacting with RNase H2 and mediating its recruitment to DSBs. a Dot plot showing the
normalized number of overlaps relative to random of γH2AX and RNASEH2A signals in S-phase cells knocked-down for BRCA2 and treated with NCS. At
least n= 50 events were counted from two independent experiments. Lines represent mean ± s.e.m. b Representative images of PLA between RNASEH2A
and γH2AX in not irradiated (no ir) or irradiated (2 Gy) HeLa-FUCCI cells knocked-down for BRCA2. Scale bar: 10 μm. Dot plot shows the number of
signals per nucleus of PLA between RNASEH2A and γH2AX in cells knocked-down for BRCA2. At least n= 150 cells were counted from three independent
experiments. Lines represent mean ± s.e.m. c Co-immunoprecipitation of endogenous RNASEH2A from not irradiated (no ir) or irradiated 5 Gy (ir)
HEK293T cell extracts, prepared in the presence of benzonase to avoid contaminant nucleic acids. Asterisks indicate speciﬁc band. This experiment was
repeated three times independently with similar results. d Immunoblot of GST pull-down assessing binding of recombinant Histidin (His)-tagged RNase H2
to GST-tagged BRCA2 fragments. This experiment was repeated two times independently with similar results. e Immunoblot of streptavidin pull-down
assessing binding of recombinant Histidin (His)-tagged RNase H2 to biotinylated BRC repeats. This experiment was repeated two times independently with
similar results. f Dot plot showing the normalized number of overlaps relative to random of γH2AX and DNA:RNA hybrid signals in S-phase cells knocked-
down for BRCA2 and treated with NCS. At least n= 50 events were counted from two independent experiments. Lines represent mean ± s.e.m. g DRIP-
qPCR at 1.5 kb on the right from the I-PpoI cut site within DAB1 gene in S/G2-phase-sorted HeLa-FUCCI cells knocked-down for BRCA2 and transfected
with the I-PpoI nuclease. The bar graph shows the average fold induction of cut samples relative to uncut from n= 3 independent experiments. Error bars
represent s.e.m. *P < 0.05, ***P < 0.001 (two-tailed Student’s t test). (RH2 is RNase H2; RH2A is RNASEH2A). Uncropped blots are shown in
Supplementary Fig. 8. Source data are provided as a Source Data ﬁle
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replaced with fresh media and cells were harvested 3 days after. In both cases,
before transfection, the ASO solution was incubated at 95 °C for 5 min and chilled
on ice for 5 min to prevent the formation of secondary structures of the
oligonucleotides. ASO sequences are listed in Supplementary Data 2.
Inhibition of RNA polymerase II transcription. RNA polymerase II transcription
was inhibited by treatment with α-amanitin (50 μg/ml) (Sigma-Aldrich) or 5,6-
dichloro-1-β-D-ribofuranosylbenzimidazole (DRB, 50 μM) (Sigma-Aldrich),
respectively dissolved in deionized water and Dimethyl sulfoxide (DMSO).
Immediately after adding the drugs, HeLa cells were irradiated (5 Gy) and then
ﬁxed 6 h later. For α-amanitin treatment, before adding the drug to the medium,
cells were mildly permeabilized with 2% Tween 20 in phosphate-buffered saline
(PBS) 1× for 10 min at room temperature (RT). RT-qPCR analysis of the levels of
c-FOS, a short-lived RNA speciﬁcally transcribed by RNA pol II, was used to
monitor the efﬁcacy and speciﬁcity of the drugs.
RNase H treatment. U2OS cells were plated on coverslips and irradiated (2 Gy).
One hour later cells were permeabilized with 0.2% Tween 20 in PBS 1× for 10 min
at RT. After two washes in PBS 1×, each coverslip was incubated for 30 min at RT
with 15 U RNase H (USB corporation) diluted in 200 μl PBS with 5 mM MgCl264.
Next, coverslips were washed twice in PBS 1× and ﬁxed and stained as described in
the “Immunoﬂuorescence and imaging analysis” section.
RNA extraction. Total RNA from cultured cells was extracted with Maxwell® RSC
simplyRNA Tissue Kit with the Maxwell® RSC Instrument (Promega), according to
manufacturer instructions.
For dilncRNAs detection, chromatin-bound RNA was extracted as follows.
Cells were fractionated according to a published protocol65. The obtained
chromatin fraction was treated with 50 U of Turbo DNase (Ambion) for 10 min at
37 °C and then digested with with 200 μg of Proteinase K (Roche) for 10 min at 37 °
C. The RNA was then puriﬁed with Maxwell® RSC simplyRNA Tissue Kit.
Standard RT-qPCR and strand-speciﬁc RT-qPCR. For standard RT-qPCR,
cDNA was obtained using the SuperScript VILO Reverse Transcriptase (Life
Technologies), according to manufacturer instructions. Roche SYBR Green-based
RT-qPCR experiments were performed on a Roche LightCycler 96 or 480 machine.
RPPO was used as normalizer.
For dilncRNAs detection, chromatin-bound RNA was retro-transcribed using
the Superscript IV First Strand cDNA synthesis kit (Invitrogen) with strand-
speciﬁc primers. Expression of dilncRNAs was determined by RT-qPCR using
EvaGreen Supermix (Bio-Rad). For dilncRNAs detection in DIvA cells, RT was
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performed with the primer “AsiSI_non genic_1.5 Rev” and qPCR with primers
“AsiSI_non genic_0.5”. 7SK was used as normalizer. For dilncRNAs detection at
the I-PpoI cut site, RT was performed with the primer “DAB1+ 1.5_Rev” and
qPCR with primers “DAB1+ 1.5”. 47S was used as normalizer. See Supplementary
Data 3 for a complete list of primers used.
Immunoﬂuorescence and imaging analysis. Cells were ﬁxed in 4% paraf-
ormaldehyde (PFA) for 10 min at RT. For BRCA2 staining cells were ﬁxed in ice-
cold methanol for 10 min. Immunoﬂuorescence was performed as described
previously17,18. Secondary antibodies used were: goat anti-rabbit or anti-mouse
Alexa 488 IgG (Life Technologies); donkey anti-mouse or anti-rabbit Cy3 IgG
(Jackson Immuno Research), donkey anti-mouse or anti-rabbit Alexa 647 IgG (Life
Technologies). For BrdU native staining cells were incubated with BrdU (Sigma-
Aldrich, 10 µg/ml) for 24 h.
Immunoﬂuorescence images were acquired using a wideﬁeld Olympus
Biosystems Microscope BX71 and the MetaMorph software (Soft Imaging System
GmbH). Confocal sections were obtained with a Leica TCS SP2 or AOBS confocal
laser microscope by sequential scanning. Comparative immunoﬂuorescence
analyses were performed in parallel with identical acquisition parameters. Images
were analyzed by CellProﬁler 2.1.1 software66.
Super-resolution imaging. Super-resolution (SR) experiments were performed on
U2OS cells seeded on coverslips and synchronized as described in “Cell culture”
section. Upon DNA damage induction, cells were pre-extracted at RT for 3 min in
CSK buffer (10 mM Hepes, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, and
0.5% Triton X-100, pH 7.4) and ﬁxed for 15 min in PFA (3.7% from 32% EM
grade, Electron Microscopy Sciences, 15714) and glutaraldehyde (0.3% from 70%
EM grade, Sigma-Aldrich, G7776) in PBS. Blocking was performed in blocking
buffer (2% glycine, 2% bovine serum albumin (BSA), 0.2% gelatin, and 50 mM
NH4Cl in PBS) for 1 h at RT. Primary antibodies used are listed in Supplementary
Data 4. Immediately before imaging analysis, coverslips were mounted onto a
microscope microﬂuidics chamber and freshly prepared SR imaging buffer, com-
prising an oxygen scavenging system including 1 mg/ml glucose oxidase (Sig-
maAldrich, G2133), 0.02 mg/ml catalase (SigmaAldrich, C3155), 10% glucose
(SigmaAldrich, G8270), and 100 mM mercaptoethylamine (Fisher Scientiﬁc,
BP2664100) in PBS, was added to the imaging chamber. Images were acquired with
a custom-built SR microscope based on a Leica DMI 3000 inverted microscope. For
each ﬁeld 2000 sequential frames of single molecule emissions at 40 Hz were col-
lected and imaged on an electron-multiplying charged coupled device (EMCCD,
Andor) using Solis software (Andor). Each raw image stack was processed for
single molecule localization and rendered using 20 nm pixels via rapidSTORM or
QuickPALM. Monte Carlo simulations were used to randomly rearrange the
clusters within an ROI to calculate a baseline level of random colocalization. Using
this approach, 20 random simulations were generated for each nucleus in a pair-
wise fashion. The total number of overlaps detected in each nucleus (typically
15–100) was normalized to the determined random level of overlap by dividing the
number of real overlaps by the average number of overlaps in the same randomly
simulated nucleus. For display purposes, images were smoothed by applying a
Gaussian blur ﬁlter and colors were thresholded for optimal production of a clear
picture of the single foci.
Proximity ligation assay. Cells were labeled according to the manufacturer’s
instructions (Sigma). Brieﬂy, cells were ﬁxed as described in the section “immu-
noﬂuorescence and imaging analysis” and incubated with primary antibodies
overnight at 4 °C. Proximity ligation assay (PLA) probes (secondary antibodies
conjugated with oligonucleotides) were added to the samples. After ligation of the
oligonucleotide probes in close proximity (<40 nm), ﬂuorescently labeled oligo-
nucleotides were added together with a DNA polymerase to generate a signal
detectable by a ﬂuorescence microscope. Images were acquired using a wideﬁeld
Olympus Biosystems Microscope BX71 and the MetaMorph software (Soft Ima-
ging System GmbH) and quantiﬁcation of PLA dots was performed with the
automated image-analysis software CellProﬁler 2.1.1.
DR-GFP and TLR reporter assay. TLR experiments were performed using
HEK293 TLRsce cells. IFP-tagged I-SceI and BFP-tagged donor GFP template were
transfected together with ASOs, as described in “Transfections” section. After 72 h,
the HR and mutagenic NHEJ efﬁciency was determined by ﬂow cytometry analysis
of the % of GFP- and mCherry- positive cells, respectively, on the gated IFP- and
BFP-double-positive cell population, as described in the section “Fluorescence-
activated cell sorting”.
I-SceI expression in TRI-DR-U2OS cells was induced by adding 5 μg/ml
doxycycline and 72 h later the HR efﬁciency was determined by quantifying GFP-
positive cells (product of successful HR) by ﬂow cytometry, as described in the
section “Fluorescence-activated cell sorting”. A PCR method was also used to
monitor HR and SSA. DNA was extracted with the DNeasy Blood & Tisue Kit
(Qiagen) and PCR was performed with the GoTaq® DNA Polymerase (Promega).
HR was monitored by measuring the intensity of the amplicon generated by the
primers P1 and P267,68. SSA was monitored by measuring the intensity of the
amplicon generated by ampliﬁcation with primer F1 and R267,68. Both the
measurements were normalized on the actin amplicon. Sequences of the primers
are listed in Supplementary Data 3. Ampliﬁcations were performed using the
following program and were determined to be in the linear range:
For P1-P2 primers: 98 °C/5 min × 1 cycle; 98 °C/45 s, 70 °C/30 s, and 72 °C/30
s × 30 cycles; 72 °C/10 min × 1 cycle.
For F1-R2 primers: 98 °C/45 s × 1 cycle; 98 °C/10 s, 50 °C/30 s, and 72 °C/60 s ×
25 cycles; 72 °C/2 min × 1 cycle.
For Actin primers: 95 °C/5 min × 1 cycle; 95 °C/30 s, 62 °C/30 s, and 72 °C/30
s × 25 cycles; 72 °C/10 min × 1 cycle.
Totally, 10 μl of the PCR products was loaded on a 1% agarose gel and
visualized by Gel Red staining. Images were acquired with Chemidoc imaging
system (Bio-Rad) and densitometric analysis was performed using the Image Lab
5.2 software.
Immunoblotting. Cells were lysed in Laemmli sample buffer (2% sodium dodecyl
sulfate (SDS), 10% glycerol, 60 mM Tris-HCl pH 6.8). Protein concentration was
determined by the biochemical Lowry protein assay and the desired amount of
protein was mixed with bromophenol blue and dithiothreitol (DTT), heated at
95 °C for 5 min, and resolved by SDS polyacrylamide gel electrophoresis (SDS-
PAGE). After transferring on a nitrocellulose membrane (0.45 mm) (400 mA; 1 h)
in transfer buffer (25 mM Tris-HCl, 0.2 M Glycine, 20% methanol), membranes
were blocked with 5% milk in TBS-T buffer (Tween 20, 0.1%) for 1 h at RT and
next incubated overnight at 4 °C with primary antibodies diluted in in 5% milk in
TBS-T (see Supplementary Data 4). Next, the membranes were washed with TBS-T
three times for 10 min and incubated with secondary horseradish peroxidase
(HRP)-conjugated antibodies (Bio-rad) diluted in 5% milk in TBS-T. After 3 more
washes with TBS-T, HRP activity was detected using a Chemidoc imaging system
(Bio-Rad) machine after adding the substrate for the enhanced chemiluminescent
reaction ECL (GE Healthcare). Uncropped scans for main ﬁgure blots are shown in
Supplementary Fig. 8.
Immunoprecipitation. HEK293T cells were collected and lysed in TEB150 lysis
buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 2 mM MgCl2, 5 mM EGTA pH 8,
1 mM DTT, 0.5% Triton X-100, 10% glycerol, protease inhibitor cocktail set III
(Calbiochem) and Benzonase 1:1000 (Sigma) for 45 min at 4 °C. Usually, 1 mg of
the protein lysate was used per each immunoprecipitation in a reaction volume of
500 μl. As input, 1% of the immunoprecipitation reaction was collected and
denatured in the sample buffer (50 mM Tris-HCl pH 6.8; 2% SDS; 10% glycerol;
12.5 mM EDTA; 0.02% bromophenol blue; 100 μM DTT) for 10 min at 95 °C.
Unspeciﬁc binding of proteins to the beads was reduced by incubating samples
with Protein G beads (50 μl) (Zymed Laboratories) for 1 h at 4 °C (preclearing).
Binding reactions were performed overnight at 4 °C and were followed by addition
of protein Glutathione–Sepharose beads for 2 h. After 3–6 washes with lysis buffer,
immunoprecipitated proteins were released by the addition of sample buffer and
incubation at 95 °C for 10 min.
GST and streptavidin pull-down experiments. GST and streptavidin pull-down
experiments were performed as described in58. Recombinant human RNase H2
with a His-tag at the C-terminus of RNASEH2B (a gift from M. Reijns and A.
Jackson) was puriﬁed as previously described32. Brieﬂy, GST-BRCA2 fragments
bound to Glutathione–Sepharose beads or biotin-BRC peptides bound to strepta-
vidin beads were incubated with His-tagged RNase H2 in binding buffer (50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 5 mM EDTA, 1 mM PMSF, 10 mM
NaF, complete protease inhibitor cocktail (Roche)) for 20 min at RT. The beads
were then extensively washed with the binding buffer and bound proteins were
resolved with 4–12% MES before Western blotting.
Chromatin immunoprecipitation. ChIP was performed as described previously17.
Brieﬂy cells were cross-linked and chromatin was sonicated with a Focused-
Ultrasonicator Covaris to obtained fragments of ~500 bp. 20 μg of chromatin were
used per sample for γH2AX, BRCA1, and RAD51 ChIP; 50 μg for RPA ChIP, and
100 μg for RNASEH2A ChIP. DNA was cleaned up by QIAquick PCR puriﬁcation
column (Qiagen) according to the manufacturer’s instructions and Roche SYBR
Green-based qPCR experiments were performed on a Roche LightCycler 96 or 480
machine (see Supplementary Data 3 for primers sequence).
DNA:RNA hybrids immunoprecipitation. DRIP was performed following a
published protocol43. Brieﬂy, DNA was extracted gently with phenol:chloroform:
isoamyl alcohol (Sigma-Aldrich cat. no. P2069) and digested with HindIII, EcoRI,
BsrGI, XbaI, and SspI (NEB). After puriﬁcation from restriction enzymes, half of
the DNA was treated overnight with RNase H (NEB). In the meantime, serum-free
medium containing the S9.6 antibody (kind gift from D. Piccini and M. Foiani) was
mixed with protein A and protein G Dynabeads (Invitrogen) and incubated on a
rotating wheel overnight at 4 °C. After a further puriﬁcation step, 4 μg of DNA was
used for each IP. After elution from the beads, DNA was cleaned up with QIAquick
PCR puriﬁcation column (Qiagen) according to the manufacturer’s instructions.
The indicated regions were ampliﬁed by Roche SYBR Green-based qPCR on a
Roche LightCycler 480 machine (see Supplementary Data 3 for primers sequence).
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The signal intensity plotted is the relative abundance of DNA–RNA hybrid
immunoprecipitated in each region, normalized to input values.
Fluorescence-activated cell sorting. For DR-GFP and TLR experiments, cells
were ﬁxed in 1% formaldehyde for 20 min on ice. Next, cells were washed in PBS
with 1% BSA and ﬁxed in 75% ethanol. Fixed cells were washed again in PBS with
1% BSA and stained with propidium iodide (PI) (Sigma-Aldrich, 50 µg/ml) in PBS
supplemented with RNase A (Sigma-Aldrich, 250 µg/ml). For cell cycle analysis,
cells were directly ﬁxed in 75% ethanol, as described above. Samples were acquired
on an Attune NxT machine and analyzed with FlowJo_V10 software. At least 104
events were analyzed per sample.
For sorting of HeLa-FUCCI cells, cells were collected in PBS with 2% FBS and
the G1 and S/G2 population were sorted with a MoﬂoAstrios (Beckman Coulter) in
PBS supplemented with RNaseOUT (Thermo Fisher). Sorted samples were
processed for DRIP as described in the section “DNA:RNA hybrids
immunoprecipitation”.
Cloning, expression, and puriﬁcation of recombinant proteins. Recombinant
BRCA1 was expressed and puriﬁed as a complex in Sf9 cells by co-infection with
baculoviruses prepared from individual pFastBac1 plasmids pFB-2xMBP-BRCA1-
10×His. Bacmids, primary and secondary baculoviruses were obtained using
standard procedures according to manufacturer’s instructions (Bac-to-Bac,
Life Technologies). Sf9 cells were transfected using a Trans-IT insect reagent
(Mirus Bio).
For the large-scale BRCA1 expression and puriﬁcation, Sf9 cells were seeded at
0.5 × 106 per ml and infected 16 h later with recombinant baculoviruses expressing
pFB-2×MBP-BRCA1-10×His. The infected cells were incubated in suspension at 27 °C
for 52 h with constant agitation. All puriﬁcation steps were carried out at 4 °C or on
ice. The Sf9 cell pellets were resuspended in three volumes of lysis buffer (Tris-HCl, pH
7.5, 50mM; Dithiothreitol (DTT), 1mM; ethylenediaminetetraacetic acid (EDTA),
1mM; protease inhibitory cocktail, Sigma P8340, 1:400; phenylmethylsulfonyl ﬂuoride
(PMSF), 1mM; leupeptin, 30 μg/ml; NP40, 0.5%) for 20min with continuous stirring.
Glycerol was added to 16% (v/v) concentration. Next, 5M NaCl was added slowly to
reach a ﬁnal concentration of 305mM. The cell suspension was further incubated for
30min with continuous stirring, centrifuged at 57,800 g for 30min to obtain soluble
extract. Pre-equilibrated amylose resin (New England Biolabs) was added to the cleared
soluble extract and incubated for 1 h with continuous mixing. The resin was then
collected by centrifugation at 2000 g for 2min and washed extensively batch wise as
well as on disposable columns (Thermo Scientiﬁc) with wash buffer (Tris-HCl, pH 7.5,
50mM; β-mercaptoethanol, 2mM; NaCl, 300mM; glycerol, 10%; PMSF, 1mM; NP40,
0.5%). Protein was eluted with wash buffer containing 10mM maltose (Sigma). The
eluates were further treated with PreScission protease for 90min to cleave off the
maltose binding protein afﬁnity tag (MBP). The sample was then supplemented with
20mM imidazole and further incubated with pre-equilibrated Ni-NTA agarose resin
(Qiagen) for 1 h. The Ni-NTA resin was transferred on a disposable column and
washed extensively with Ni-NTA wash buffer (Tris-HCl, pH 7.5, 50mM; β-
mercaptoethanol, 2 mM; NaCl, 1M; glycerol, 10%; PMSF, 1mM; imidazole, 20mM).
Prior to elution, the protein was washed once with the same Ni-NTA wash buffer listed
above but with only 150mM NaCl. Pooled fractions were stored at −80 °C.
Electrophoretic mobility shift assay. The 50 bp-long dsDNA substrate was
prepared by annealing oligonucleotides X12-3 (5′GACGTCATAGACGATTA
CATTGCTAGGACATGCTGTCTAGAGACTATCGC3′) and X12-4C (5′GCGA
TAGTCTCTAGACAGCATGTCCTAGCAATGTAATCGTCTATGACGTC 3′’) as
previously described69. The 50 bp-long DNA:RNA hybrid substrate was prepared
by annealing X12-3 DNA and X12-4C RNA. BRCA1 was incubated for 30 min at
37 °C with 10 nM dsDNA or DNA:RNA hybrid substrate in a reaction buffer
containing Tris-HCl pH 7.5, 25 mM; KCl, 90 mM; EDTA pH 8.0, 1 mM; DTT,
1 mM; BSA (NEB), 0.1 mg/ml; RNaseOUT (Invitrogen).
The cold competitor experiments were done by pre-binding BRCA1-BARD1 to
1 nM radiolabeled dsDNA or DNA:RNA at 37 °C for 10 min. Cold dsDNA or
DNA:RNA was then added to the reaction and incubated for another 10 min before
analyzing products on a gel. The salt titration experiments were done using the
same conditions with the given salt concentrations. After the binding reaction,
loading dye (5 μL; 50% glycerol; Tris-HCl pH 7.5, 20 mM; EDTA, 0.5 mM;
bromophenol blue) was added to reactions and products were separated by 6%
non-denaturing polyacrylamide gel electrophoresis at 4 °C. The gels were dried on
17CHR ﬁlter paper (Whatman), exposed to storage phosphor screens, and scanned
by a Typhoon Phosphor imager (FLA 9500, GE Healthcare). Quantiﬁcation of
protein-bound substrates was done using Imagequant software.
DRIP-seq and BLISS data analysis. DRIP-seq raw FASTQ data were retrieved
from the European Nucleotide Archive public repository (https://www.ebi.ac.uk/
ena/data/view/PRJEB24001). Alignment was performed as described in ref. 30: raw
reads were aligned to the human genome (GRCh37/hg19 assembly) using BWA70,
and aligned reads were processed and duplicates were removed using SAMtools71.
The log2 ratio of the fold enrichment of cut vs uncut DRIP-seq samples, was
calculated using bamCompare (settings: --binSize 50 --normalizeUsing RPKM
--outFileFormat bedgraph) from the suite DeepTools72. To calculate the distribu-
tion proﬁle of DNA:RNA hybrids enrichment at DSBs, the log2 ratio values cal-
culated for each 50 bp bin for DRIP-seq reads were intersected to ﬁve distance
intervals from the top 50 cut AsiSI sites (determined in our laboratory50): 0–0.5,
0.5–1, 1–1.5, 1.5–2, and 2–2.5 kb requiring a minimum overlap of 90% of the bin
using intersectBed tool from BedTools suite73. For each AsiSI site a mean log2 ratio
value was calculated with ad hoc bash scripts among the ones of the bins over-
lapping the site. The accumulation of DNA:RNA hybrids upon DSB induction was
then measured separately at genic or non-genic AsiSI sites Data parsing, plotting,
and statistical test calculation was performed using ad hoc R scripts and publicly
available R packages.
Statistical analysis. Prism 6 software was used to generate graphs, to perform
statistical analysis and to remove outliers with the Robust regression and Outlier
removal method in Figs. 5e, 6b, and Supplementary Fig. 6d–f. Statistical analysis
was performed with the two-tailed Student’s t test, unless differently indicated.
Asterisks in the ﬁgures indicate P value: *P < 0.05, **P < 0.01, ***P < 0.001, ****P <
0.0001.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data are available from the authors upon reasonable request. A
reporting summary for this Article is available as a Supplementary Information ﬁle.
Source data are provided as a Source Data ﬁle. DRIP-seq raw FASTQ data were
retrieved from the European Nucleotide Archive public repository (https://www.
ebi.ac.uk/ena/data/view/PRJEB24001).
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